Christina Guldberg

Christina Guldberg has extensive work experience in the pharmaceutical industry. Christina is currently working as the Senior Director of Clinical Development and Outcomes Research in Rare Diseases at Initiator Pharma. Prior to this, they worked at Orphazyme as the Director of Clinical Outcomes from December 2017 to March 2022, and as the Director of Clinical Operations from March 2015 to December 2017. Christina also has experience as the Owner and Consultant of Guldberg Clinical Solutions from January 2011 to March 2015. Additionally, they worked as the Senior Project Director at BridgeBioresearch from March 2011 to June 2012. Before that, they held the role of Development and Good Clinical Practice Manager at AQM Maxval A/S in 2010 and served as the Development Project Leader at Zealand Pharma from 2005 to 2010. Christina'searlier experience includes working as an International Trial Manager at Novo Nordisk A/S from January 2002 to August 2005 and as a Clinical Research Manager at Ferring Pharmaceuticals A/S from 1993 to 2002. Christina started their career in the pharmaceutical industry as a Quality Assurance professional at ALK-abelló in 1987.

Christina Guldberg earned their M.Sc. Pharm degree in Pharmacy from Danmarks Farmaceutiske Universitet from 1980 to 1986. Additionally, they pursued further education at the University of Surrey, obtaining a PG DIP Pharm Med degree. Further details regarding the start and end years for the degree at the University of Surrey are not provided.